| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.410 | 208.872 | 290.399 | 185 | 0 | 0 | 0 | 0 | 173.883 | 345.842 |
| Total Income - EUR | 50.410 | 208.872 | 333.225 | 185 | 0 | 0 | 0 | 0 | 177.779 | 345.883 |
| Total Expenses - EUR | 59.831 | 238.930 | 324.797 | 1.912 | 1.948 | 1.024 | 1.002 | 593 | 181.230 | 377.395 |
| Gross Profit/Loss - EUR | -9.421 | -30.058 | 8.428 | -1.727 | -1.948 | -1.024 | -1.002 | -593 | -3.451 | -31.513 |
| Net Profit/Loss - EUR | -10.933 | -32.156 | 5.592 | -1.732 | -1.948 | -1.024 | -1.002 | -593 | -3.451 | -31.513 |
| Employees | 3 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Biosalus Farmacie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 77.840 | 68.564 | 17.353 | 15.970 | 14.617 | 13.315 | 12.018 | 11.462 | 10.961 | 0 |
| Current Assets | 76.478 | 132.623 | 131.585 | 90.932 | 88.814 | 82.291 | 80.467 | 80.716 | 126.440 | 89.637 |
| Inventories | 19.364 | 53.382 | 27.136 | 2.899 | 3.031 | 2.973 | 2.907 | 2.916 | 69.123 | 57.457 |
| Receivables | 56.765 | 76.615 | 51.537 | 86.916 | 84.688 | 78.244 | 76.508 | 76.746 | 53.476 | 24.065 |
| Cash | 348 | 2.625 | 52.912 | 1.117 | 1.095 | 1.075 | 1.051 | 1.054 | 3.840 | 8.114 |
| Shareholders Funds | -35.939 | -67.728 | -60.991 | -61.603 | -62.358 | -62.200 | -61.822 | -62.607 | -65.776 | -107.642 |
| Social Capital | 152 | 151 | 148 | 145 | 142 | 140 | 137 | 137 | 137 | 136 |
| Debts | 190.410 | 268.915 | 209.929 | 168.505 | 165.788 | 157.807 | 154.307 | 154.786 | 203.177 | 197.279 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Biosalus Farmacie Srl